Altogether, the evidence highlights the conclusive role of the SOX2‐OT/SOX2/GLI‐1 trinomial co‐expressed axis in poorer oncological treatment response, and poorer overall survival in lung cancer. This evidence concerns the gene SOX2 and lung cancer.